Transforming growth factor-β and breast cancer: Introduction
收藏相关数据集
SMAD3 and SOX4 binding profiling in human breast cell lines. SMAD3 and SOX4 binding profiling in human breast cell lines
In order to identify genes co-bound by SOX4 and SMAD3 in the context of breast cancer, different breast cell lines (HMLEs, MDA-MB-231 or HCC-1954) were used. Due to low endogenous expression levels fo
NIAID Data Ecosystem80
UAG readthrough in mammalian cells: Effect of upstream and downstream stop codon contexts reveal different signals
BACKGROUND: Translation termination is mediated through an interaction between the release factors eRF1 and eRF3 and the stop codon within its nucleotide context. Although it is well known that the nu
PubMed Central2001-02-27 更新40
Supplementary Table S4 from SMARCA4 Inhibits Breast Cancer Progression and Metastasis through RHOA Suppression
Supplementary Table S4
Figshare2025-05-15 更新30
Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.
We have found several genetic changes in the TGF-beta-type II receptor gene in human gastric cancer cell lines resistant to the growth inhibitory effect of TGF-beta. Southern blot analysis showed dele
PubMed Central1994-09-13 更新40
Dietary ligands diindolylmethane and resveratrol result in diverse ERα signaling not seen after E2 and a subset of diindolylmethane mediated signaling needs concurrent AHR activation.. Dietary ligands diindolylmethane and resveratrol result in diverse ERα signaling not seen after E2 and a subset of diindolylmethane mediated signaling needs concurrent AHR activation.
Inhibitory crosstalk between estrogen receptor alpha (ER alpha ) and aryl hydrocarbon receptor (AHR) regulates 17-estradiol (E2)-dependent breast cancer cell signaling. ER alpha and AHR are transcript
NIAID Data Ecosystem40
